[The guideline of prevention and treatment for chronic hepatitis B: a 2015 update]

[Article in Chinese]

Affiliations

[Article in Chinese]

Chinese Society of Hepatology, Chinese Medical Association et al. Zhonghua Gan Zang Bing Za Zhi. 2015 Dec.

. 2015 Dec;23(12):888-905.

doi: 10.3760/cma.j.issn.1007-3418.2015.12.002.

No abstract available

Figures

1. Ott JJ,Stevens GA,Groeger J,et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity[J]. Vaccine, 2012,30(12):2212-2219. - PubMed
1. Lozano R,Naghavi M,Foreman K,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012,380(9859):2095-2128. - PMC - PubMed
1. Goldstein ST,Zhou F,Hadler SC,et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact[J]. Int J Epidemiol, 2005,34(6):1329-1339. - PubMed
1. Wang FS,Fan JG,Zhang Z,et al. The global burden of liver disease: The major impact of China[J]. Hepatology, 2014,60(6):2099-2108. - PMC - PubMed
1. Fung J,Seto WK,Lai CL,et al. Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy[J]. J Hepatol, 2011,54(2):195-200. - PubMed